Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Priming”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01489618
What this trial is testing

"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency

Who this might be right for
Common Variable Immunodeficiency
Institut National de la Santé Et de la Recherche Médicale, France 45
Testing effectiveness (Phase 2)Study completedNCT00140374
What this trial is testing

Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)

Who this might be right for
Prostate Cancer
Cell Genesys 36
Testing effectiveness (Phase 2)UnknownNCT04998240
What this trial is testing

Mix and Match Heterologous Prime-Boost Study Using Approved COVID-19 Vaccines

Who this might be right for
Covid19
International Vaccine Institute 360
Large-scale testing (Phase 3)Study completedNCT00002942
What this trial is testing

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 136
Early research (Phase 1)WithdrawnNCT01927835
What this trial is testing

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT02860650
What this trial is testing

Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 72
Testing effectiveness (Phase 2)Study completedNCT00814385
What this trial is testing

Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04

Who this might be right for
Influenza
University Hospitals, Leicester 606
Early research (Phase 1)Study completedNCT03816878
What this trial is testing

Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 32
Not applicableLooking for participantsNCT05500755
What this trial is testing

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

Who this might be right for
Dental Implants
Aula Dental Avanzada 150
Post-approval studies (Phase 4)UnknownNCT01841671
What this trial is testing

Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine

Who this might be right for
Polio
University of Chile 570
Testing effectiveness (Phase 2)Study completedNCT00085423
What this trial is testing

Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center 20
Post-approval studies (Phase 4)Study completedNCT01856374
What this trial is testing

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Who this might be right for
Multi-vessel Diseases, Angina
Yonsei University 60
Testing effectiveness (Phase 2)UnknownNCT02318225
What this trial is testing

Misoprostol Prior to Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain

Who this might be right for
Pain
Cairo University 100
Not applicableEnded earlyNCT02292823
What this trial is testing

MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction

Who this might be right for
ST Elevation Myocardial Infarction
InspireMD 63
Early research (Phase 1)Study completedNCT05233826
What this trial is testing

Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19

Who this might be right for
COVID-19SARS-CoV-2
Codagenix, Inc 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07347340
What this trial is testing

Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve

Who this might be right for
Diminished Ovarian Reserve (DOR)
Peking Union Medical College Hospital 348
Testing effectiveness (Phase 2)Study completedNCT00490074
What this trial is testing

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 147
Not applicableStudy completedNCT04989348
What this trial is testing

Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol

Who this might be right for
IVF
Shanghai First Maternity and Infant Hospital 240
Not applicableActive Not RecruitingNCT04313114
What this trial is testing

The PRIME-CRC Trial to Promote CRC Screening in Rural Communities

Who this might be right for
Colorectal Cancer
Louisiana State University Health Sciences Center Shreveport 804
Testing effectiveness (Phase 2)Study completedNCT01414504
What this trial is testing

Pneumococcal Conjugate Vaccine Followup

Who this might be right for
Immune Tolerance
William Pomat 280
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation